Noncompaction cardiomyopathy epidemiology and demographics

Noncompaction Cardiomyopathy Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification & Nomenclature
Pathophysiology
Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders
Epidemiology & Demographics
Screening
Natural History, Complications & Prognosis
Differentiating Noncompaction Cardiomyopathy from other Diseases
Diagnosis
History & Symptoms
Physical Examination
Laboratory Studies
Genetic Testing
Electrocardiogram
Holter Monitoring
Chest X Ray
MRI
CT
Echocardiography
Biopsy
Treatment
Medical Therapy
Surgery
Noncompaction cardiomyopathy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Noncompaction cardiomyopathy epidemiology and demographics
CDC on Noncompaction cardiomyopathy epidemiology and demographics
Noncompaction cardiomyopathy epidemiology and demographics in the news
Blogs on Noncompaction cardiomyopathy epidemiology and demographics
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Noncompaction cardiomyopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

This is a rare genetic disorder. The incidence may increase as imaging modalities improve .

==Incidence in Children==

The incidence is estimated to be 0.12 cases per 100,000 children .

Incidence in Infants

Others have estimated the rate to be as high as 0.81 per 100,000 infants per calender year.

Male Predominance

There is an excess incidence of the disease in males (56% to 82%). This has been taken as evidence that in some cases there may be x-linked inheritance.